JLE

European Journal of Dermatology

MENU

Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years Volume 24, issue 3, May-June 2014

Tables

Authors
Alain Beauchet for the Groupe d’Etudes Multicentriques RESOPSO 16
1 Department of Dermatology,
Bichat Claude Bernard Hospital,
APHP
Paris Diderot University
46 rue Henri Huchard,
75877 Paris Cedex 18,
France
2 Department of Dermatology,
Hôpital Victor Dupouy,
Argenteuil,
France
3 Department of Dermatology,
Hôpital d’Instruction des Armées Bégin,
Saint-Mandé,
France
4 Department of Dermatology,
CH de Pontoise,
Pontoise,
France
5 Department of Dermatology,
CH d’Auxerre,
Auxerre,
France
6 Department of Dermatology,
CHU de Reims,
Reims,
France
7 Department of Dermatology,
CH du Mans,
Le Mans,
France
8 Department of Dermatology,
CH Régional d’Orléans,
Orléans,
France
9 Department of Dermatology,
Hôpital Sud,
CHU d’Amiens,
Amiens,
France
10 Martigues,
France
11 Vienne,
France
12 Department of Dermatology,
CH Intercommunal Poissy/Saint-Germain-en-Laye,
Saint-Germain-en-Laye,
France
13 Department of Dermatology,
Hospital of Angers,
Angers,
France
14 Department of Clinical Immunology and Allergy,
CHU Lyon-Sud,
Lyon,
France
15 Department of Dermatology,
CHU de Bordeaux,
Bordeaux,
France
16 Department of Public Health,
CHU Ambroise Paré,
University of Versailles-Saint Quentin en Yvelines,
APHP,
Boulogne-Billancourt,
France
* Reprints

Background: Whereas several studies have underlined the association between severe psoriasis and metabolic syndrome (MetS), the association of androgenetic alopecia (AGA) and MetS have yielded inconsistent results. Objective: To investigate the relationship between AGA and the components of MetS in a population of psoriatic male patients. Methods: A non-interventional, cross-sectional, multicenter study was conducted in France. A standardized questionnaire was completed, including information on components of MetS and other possible risk factors. MetS was defined in this study as a combination of three or more of the four components of MetS: waist circumference, hyperlipidemia, diabetes mellitus and hypertension. In addition, a standardized simplified Norwood classification limited into 5 grades (0-4) was used. Results: In a total of 1073 male patients, hypertension, high waist circumference, diabetes mellitus and hyperlipidemia were observed in 28%, 59%, 11%, and 31%, respectively. In age-adjusted multivariate analysis, severe AGA (grade 3-4 versus grade 0) was associated with the presence of at least one component of MetS. By groups of age, a statistically significant association of severe AGA and MetS was demonstrated in patients over 59 years. Severe AGA was also associated with a first degree familial history of major cardiovascular event in patients older than 59 years. Conclusions: Our study, based on a simplified but stringent definition of MetS, confirmed the link between severe AGA and individual components of MetS in psoriatic patients. This argues for careful follow-up with regular screening in male psoriatic patients with severe AGA in order to early detect determinants of MetS.